1 |
Rouzier R, Perou CM, Symmans WF, et al (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res, 11, 5678-85.
DOI
ScienceOn
|
2 |
Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74.
DOI
ScienceOn
|
3 |
Su Y, Zheng Y, Zheng W, et al (2010). Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer, 11, 292.
|
4 |
Webster LR, Lee SF, Ringland C, et al (2008). Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification. Clin Cancer Res, 14, 6625-33.
DOI
ScienceOn
|
5 |
Caudle AS, Yu TK, Tucker SL, et al (2012). Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res, 14, 83.
DOI
|
6 |
Allred DC, Harvey JM, Berardo M, Clark GM (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 2, 155-68.
|
7 |
Bair E, Tibshirani R (2004). Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol, 4, 108.
|
8 |
Bennis S, Abbass F, Akasbi Y, et al (2012). Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study. BMC Res Notes, 5, 436.
DOI
|
9 |
Blows FM, Driver KE, Schmidt MK, et al (2010). Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med, 5, 1000279.
|
10 |
Carey LA, Dees EC, Sawyer L, et al (2007). The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res, 13, 2329-34.
DOI
ScienceOn
|
11 |
Chen XS, Ma CD, Wu JY, et al (2010). Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer. Tumori, 96, 103-10.
|
12 |
Haghighat S, ME Akbari ME, Ghaffari S, Yavari P (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac Cancer Prev, 13, 5525-8.
과학기술학회마을
DOI
ScienceOn
|
13 |
Jana D, Mandal S, Mukhopadhyay M, et al (2012). Prognostic Significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India. Asian Pac J Cancer Prev, 13, 3851-5.
과학기술학회마을
DOI
ScienceOn
|
14 |
King WJ, Greene GL (1984). Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature, 307, 745-7.
DOI
ScienceOn
|
15 |
Layfield LJ, Saria E, Mooney EE, Liu K, Dodge RR (1998). Tissue heterogeneity of immunohistochemically detected estrogen receptor. Implications for image analysis quantification. Am J Clin Pathol, 110, 758-64.
|
16 |
Kadivar M, Mafi N, Joulaee A, Shamshiri A, Hosseini N (2012). Breast cancer molecular subtypes and associations with clinicopathological characteristics in Iranian women. Asian Pac Cancer Prev, 13, 1881-6.
과학기술학회마을
DOI
ScienceOn
|
17 |
Khokher S, Qureshi MU, Mahmood S, Nagi AH (2013). Association of immunoistochemically defined molecular subtypes with clinical response to presurgical chemotherapy in patients with advanced breast cancer. Asian Pac J Cancer Prev, 14, 3223-8.
DOI
ScienceOn
|
18 |
Millar EK, Graham PH, O'Toole SA, et al (2009). Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol, 27, 4701-8.
DOI
ScienceOn
|
19 |
Noh JM, Choi DH, Huh SJ, et al (2011). Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype. J Breast Cancer, 14, 46-51.
DOI
ScienceOn
|
20 |
Ross JS, Fletcher JA, Bloom KJ, et al (2004). Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteomics, 3, 379-98.
DOI
ScienceOn
|
21 |
Voduc KD, Cheang MCU, Tyldesley S, et al (2010). Breast cancer subtypes and the risk of local and regional relapse. JCO, 28,1684-91.
DOI
ScienceOn
|
22 |
Prat A, Parker JS, Karginova O, et al (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res, 12, 68.
DOI
ScienceOn
|